Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis.
about
Poly Cystic Ovarian Syndrome: An Updated OverviewComplications and challenges associated with polycystic ovary syndrome: current perspectivesDiagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineEmotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies.Personality and psychiatric disorders in women affected by polycystic ovary syndrome.Epidemiology, diagnosis, and management of polycystic ovary syndromeTotal testosterone levels are often more than three times elevated in patients with androgen-secreting tumours.The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndromePolycystic ovary syndrome: current status and future perspectiveLongterm management of Polycystic Ovarian Syndrome (PCOS)Mood and Ambulatory Monitoring of Physical Activity Patterns in Youth with Polycystic Ovary Syndrome.Effects of testosterone on the expression levels of AMH, VEGF and HIF-1α in mouse granulosa cellsRelationship Between the Clinical and Biochemical Findings of Polycystic Ovary Syndrome and Depression and AnxietyDepression, Anxiety, and Anger in Patients with Polycystic Ovary Syndrome.Consensus on women's health aspects of polycystic ovary syndrome (PCOS).Polycystic ovary syndrome: a common but often unrecognized condition.Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about.Mood disorders and quality of life in polycystic ovary syndrome.What does a diagnostic label of 'polycystic ovary syndrome' really mean in adolescence? A review of current practice recommendations.Young women's psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis.Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical andsocio-demographic factors.Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.The predictors of quality of life in women with polycystic ovarian syndrome.High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up.Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS.Health-related quality of life in women with newly diagnosed polycystic ovary syndrome randomized between clomifene citrate plus metformin or clomifene citrate plus placebo.Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study.Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies.Prevalence of body mass index and body weight cut-off points for in vitro fertilization treatment at U.S. clinics and current clinic weight loss strategy recommendations.Predictors of Depression in Iranian Women with Polycystic Ovarian Syndrome.Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome.Psychological aspects of hyperandrogenic states in late adolescent and young women.A case report demonstrating the efficacy of a comprehensive cognitive-behavioral therapy approach for treating anxiety, depression, and problematic eating in polycystic ovarian syndrome.Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study.Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome.Pregnancy-related outcomes for women with polycystic ovary syndrome.Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS.
P2860
Q26752564-EE368D5C-01DD-4FD1-8EF0-317197021DF5Q26799566-44D2450D-7237-44A6-B290-9CB8B8DD5D15Q33587845-E05ED657-3418-41D3-9318-1696AB48FA51Q34289806-7A81C9D8-6462-4D7A-ABDE-F8384F13A059Q34496387-F0015F54-BA78-4E71-8276-412DDC84CFA4Q34658641-FCECEDC9-2A49-4FDD-81B4-293A21C29F29Q35015784-8F7FB357-03DE-4123-8383-4142CC28FEDCQ35089757-B055C66C-C891-45D7-9B91-95E075B15855Q35124537-DFAD5A0A-E878-4EC9-B500-9C14383A5FBEQ35200094-3547A8BA-B869-42BA-B39E-2C633453EEB1Q35855349-B70221E0-2B41-4D60-AF83-082A5860A250Q37108532-D10599E8-3281-47A2-A1A4-1B9589A89D6FQ37703775-3ACACDB2-5E09-4094-93A1-DD31EE95DAE6Q37703992-AF8A6FBF-1D56-40DB-B0FF-DDC845426220Q37965510-B3F84F63-5363-40A9-BBCA-312F12A35F22Q38010787-FDA19557-7569-473C-9323-DC1EFD8EBCA6Q38218598-A7BE494E-838A-4982-B821-BF5325C640C7Q38552724-72AD43BD-D9B5-4906-98EC-91149081E106Q38633475-FD8DF5BB-8F73-41C5-B85D-4D8AB09C2B18Q38842212-E407EA13-6A2B-46D0-BDC2-A48D8536DDD0Q38849555-3C314A9B-B9E3-46A8-940E-0D3BD152BD18Q38949684-F159F8F9-70DB-4355-94C1-F6B6DF913864Q38949872-56CC75A1-2F5C-4898-8086-03C5A2C0B776Q39195587-6C4E56B8-167A-4E43-AE4F-F0499965516EQ40282708-83AD6D1C-DFB2-410B-B05C-00123AB23BB3Q42384443-54A62409-EC13-4D81-A966-A41517EEB7D0Q44459107-03C12ECC-0E77-40D9-931D-9F47994232CDQ46662873-4C793902-4A73-429C-B697-E13F2893FAD9Q47102932-5B390330-911D-4C8B-AD3A-EE61070761A3Q47392125-CF9E8552-888D-427C-AB70-D166092FABC0Q47594771-27FCA146-30F7-4EFF-B9C9-37D194DB7F24Q47654765-08D63815-5EF4-4891-9116-D65737FA7D16Q47723905-FA54F5E0-F132-43D7-BA9F-77297C06B959Q47753988-4AD709B7-6E63-42CE-A7E5-FE413D5A4C61Q48105711-50BE2E5F-53A3-445D-B482-75222EADD48BQ48135858-C7F3DEA9-C7B7-45FC-BB6B-DDB2F3122B15Q48846535-80B6A695-6B98-484E-A0BF-F12264A0B618Q49959431-CCB02805-5D9A-4131-A593-A032A53BA019Q50024493-3E625891-4C98-4361-ADD9-BE9C3733D10EQ51246676-D35DD07D-1578-4655-938D-3D3325DEB457
P2860
Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased risk for abnormal de ...... atic review and meta-analysis.
@en
Increased risk for abnormal de ...... atic review and meta-analysis.
@nl
type
label
Increased risk for abnormal de ...... atic review and meta-analysis.
@en
Increased risk for abnormal de ...... atic review and meta-analysis.
@nl
prefLabel
Increased risk for abnormal de ...... atic review and meta-analysis.
@en
Increased risk for abnormal de ...... atic review and meta-analysis.
@nl
P2093
P31
P1476
Increased risk for abnormal de ...... atic review and meta-analysis.
@en
P2093
Anuja Dokras
Robert Wild
Walter Futterweit
P304
P356
10.1097/AOG.0B013E318202B0A4
P407
P577
2011-01-01T00:00:00Z